XTB arrives at its August 28 earnings date on a striking run — up 27% in the past month to PLN 166.46, with shorts almost entirely absent and the borrow market looser than it has been all year.
The lending picture is the clearest expression of where conviction sits right now. Availability has ballooned to nearly 8,800% — meaning there are roughly 88 shares available to borrow for every one currently lent out. That is not a tight market; it is a near-empty one. Borrow costs have drifted down from brief spikes above 3% in mid-June to around 0.91% today. The ORTEX short score reads 25.4, and availability has been trending wider since late June when it was near 1,750%. Every directional signal in the lending market says short sellers have all but walked away from this name. The short score ranks in the 93rd percentile on the factor model — meaning fewer than 7% of comparable stocks carry a less pressing short case.
The Street view is broadly constructive, though analyst data is now slightly stale at 15 days old. The mean price target of PLN 163.18 sits marginally below the current price of PLN 166.46 — a rare setup where the stock has effectively run through consensus. That gap is itself a data point: the 27% monthly gain has outpaced analyst revisions, leaving the Street fractionally behind the tape. On valuation, the trailing P/E is running around 11.3x and price-to-book near 7.0x — not cheap on book value, but the earnings multiple looks undemanding for a business the factor model ranks in the 99th percentile for near-term EPS momentum. The dividend score also ranks in the 96th percentile, a reminder that XTB has historically returned substantial cash to shareholders, though the most recent dividend on record in this dataset dates to 2022.
Ownership adds texture. Founder Jakub Zablocki remains the dominant holder with a 35.8% stake, unchanged since May. The only actively moving international names are BlackRock, which added 118,000 shares through to the end of July, and Vanguard Capital Management, which added a modest 23,000. Neither is a dramatic shift, but both are directionally positive. Recent insider activity is confined to equity award grants from May — no open-market buying or selling — so there is no conflicting signal from inside the company itself.
The earnings history is where the story gets more nuanced. The last two prints — in late July — produced next-day moves of +9.4% and +6.6% respectively, with five-day follow-through of +22.6% and +16.2%. Both were substantial positive reactions that helped fuel the current rally. The May 15 print was a different story: a 5% drop on the day and marginal further weakness over the following week. That earlier miss is the lone red flag in an otherwise very bullish recent reaction pattern. A stock trading above analyst targets, with shorts absent and a history of large post-earnings moves in both directions, makes the August 28 print the single most important near-term variable to track.
Among peers, the week has been mixed. SCHW added 3.7% and WT gained 3.9%, while ASHM on the LSE fell 1.9% and AZM on Milan dropped 1.2%. XTB's own 1.5% weekly dip is modest by comparison, and does little to alter a month-long trend that has left it well clear of the peer group. The next session of real consequence is not a trading day — it is the August 28 earnings release, where the pattern of outsized moves and an absence of hedging pressure will set the terms of how investors respond.
See the live data behind this article on ORTEX.
Open XTB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
